NPI Lens

John Anthony Rambharose, M.D.

NPI 1184841272ActiveIndividual· Internal Medicine, Rheumatology· Loma Linda, CA

Internal Medicine, Rheumatology (M.D.) in Loma Linda, California, licensed in CA, with an NPI issued in April 2007. Part D covered 19 prescriptions written in 2024, 100% of them generic. Argenx US, Inc. was the largest of 3 companies reporting payments in 2025, $397.25 in all, mostly food and beverage.

Overview

NPI1184841272
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedApr 19, 2007
Last updated in NPPESJul 8, 2007

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Rheumatology Primary207RR0500XG74687CA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)19 · 35 30-day fills
Total drug cost$221.32
Generic share100% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$397.25 · 3 payments from 3 companies

Top paying companies in 2025

CompanyAmountPayments
Argenx US, Inc.$137.261
Boehringer Ingelheim Pharmaceuticals, Inc.$135.001
Ucb, Inc.$124.991

What the 2025 payments were for

  • Food and Beverage$397.25 · 3 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other rheumatologists in Loma Linda

All rheumatologists in California